Chemoinformaics analysis of TETRAHYDROXYSTEARIC-ACID
| Molecular Weight | 348.48 | nRot | 16 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 1 |
| Exact Molecular Weight | 348.251 | nRing | 0 |
| Solubility: LogS | -3.831 | nHRing | 0 |
| Solubility: LogP | 5.171 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 58.8765 |
| nHD | 5 | BPOL | 36.9835 |
| QED | 0.216 |
| Synth | 2.597 |
| Natural Product Likeliness | 0.422 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.278 |
| CACO-2 | -5.382 |
| MDCK | 0.0000463 |
| BBB | 0.933 |
| PPB | 0.975937 |
| VDSS | 0.635 |
| FU | 0.0192626 |
| CYP1A2-inh | 0.083 |
| CYP1A2-sub | 0.108 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.315 |
| CYP2c9-inh | 0.168 |
| CYP2c9-sub | 0.055 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.032 |
| CYP3a4-inh | 0.026 |
| CYP3a4-sub | 0.046 |
| CL | 1.409 |
| T12 | 0.307 |
| hERG | 0.01 |
| Ames | 0.002 |
| ROA | 0.012 |
| SkinSen | 0.31 |
| Carcinogencity | 0.017 |
| EI | 0.922 |
| Respiratory | 0.407 |
| NR-Aromatase | 0.098 |
| Antiviral | Yes |
| Prediction | 0.750518 |